Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. Jul 15, 2026; 18(7): 118400
Published online Jul 15, 2026. doi: 10.4251/wjgo.v18.i7.118400
Published online Jul 15, 2026. doi: 10.4251/wjgo.v18.i7.118400
Table 4 Adjusted risk analysis of postoperative acute kidney injury, estimated by logistic regression
| Variable | No AKI (n = 58) | AKI (n = 61) | Univariate analysis | Multivariate analysis | ||
| P value | OR (95%CI) | P value | OR (95%CI) | |||
| Sodium thiosulfate | < 0.001 | 0.10 (0.03-0.38) | ||||
| No | 25 | 48 | Reference | - | ||
| Yes | 33 | 13 | < 0.001 | 0.21 (0.09-0.46) | ||
| Age | 0.70 | 1.19 (0.46-3.24) | ||||
| ≤ 59 | 25 | 27 | - | Reference | ||
| > 59 | 33 | 34 | 0.90 | 0.95 (0.46-1.97) | ||
| Sex | - | - | ||||
| Male | 29 | 30 | Reference | - | ||
| Female | 29 | 31 | 0.93 | 1.03 (0.50-2.12) | ||
| Cardiovascular comorbidities1 | ||||||
| 0 | 24 | 25 | Reference | - | - | - |
| 1 | 16 | 21 | 0.60 | 1.26 (0.53-2.97) | 0.37 | 1.68 (0.54-5.23) |
| ≥ 2 | 18 | 15 | 0.62 | 0.80 (0.33-1.94) | 0.90 | 0.93 (0.30-2.90) |
| ASA classification | ||||||
| 1 | 23 | 25 | Reference | - | - | - |
| 2 | 26 | 25 | 0.76 | 0.89 (0.40-1.95) | ||
| 3 | 9 | 11 | 0.83 | 1.12 (0.39-3.20) | ||
| Reduced IP dose | ||||||
| No | 40 | 42 | Reference | - | - | - |
| Yes | 18 | 19 | 0.99 | 1.01 (0.46-2.19) | 0.13 | 0.41 (0.13-1.28) |
| Neoadjuvant chemo | ||||||
| No | 43 | 49 | Reference | - | - | - |
| Yes | 15 | 12 | 0.42 | 0.70 (0.30-1.66) | ||
| Chemotherapy naive | ||||||
| No | 33 | 36 | Reference | - | - | - |
| Yes | 25 | 25 | 0.82 | 0.92 (0.44-1.90) | ||
| Operation time | ||||||
| ≤ 537 minutes | 39 | 21 | Reference | - | - | - |
| > 537 minutes | 19 | 40 | < 0.001 | 3.91 (1.83-8.37) | 0.22 | 1.99 (0.67-5.96) |
| Intraoperative bleeding | ||||||
| ≤ 600 mL | 35 | 30 | Reference | 1.57 (0.76-3.25) | 0.10 | 2.26 (0.86-5.94) |
| > 600 mL | 23 | 31 | 0.22 | |||
| Intraoperative hypotension (minute)3 | ||||||
| None | 34 | 28 | Reference | - | - | - |
| 0-7.12 | 8 | 7 | 0.92 | 1.06 (0.34-3.29) | 0.51 | 0.60 (0.13-2.74) |
| > 7.12 | 15 | 26 | 0.07 | 2.11 (0.94-4.73) | 0.06 | 2.82 (0.98-8.16) |
| Peak lactic acid level | ||||||
| < 2.4 | 34 | 28 | Reference | - | - | - |
| ≥ 2.4 | 24 | 33 | 0.17 | 1.67 (0.81-3.45) | 0.92 | 0.95 (0.34-2.64) |
| Postoperative inotropy4 | ||||||
| ≤ 32 hours | 35 | 37 | Reference | - | - | - |
| > 32 hours | 21 | 22 | 0.98 | 0.99 (0.47-2.11) | 0.55 | 0.75 (0.28-1.97) |
| Complications | ||||||
| No complication | 31 | 28 | Reference | - | - | 0.40 (0.13-1.19) |
| < 3b | 24 | 22 | 0.97 | 1.02 (0.47-2.20) | 0.10 | - |
| ≥ 3b | 3 | 11 | 0.05 | 4.06 (1.03-16.1) | 0.13 | 4.43 (0.64-30.5) |
| Sepsis with AKI | 0 | 4 | 0.05 | N/A2 | - | - |
- Citation: Algethami N, Valdimarsson V, Verwaal V, Syk I. Prophylactic sodium thiosulfate reduces the risk and severity of acute kidney injury in oxaliplatin-based hyperthermic intraperitoneal chemotherapy. World J Gastrointest Oncol 2026; 18(7): 118400
- URL: https://www.wjgnet.com/1948-5204/full/v18/i7/118400.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v18.i7.118400